These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11472583)

  • 1. Measles seroprevalence in Izmir with special emphasis on measles vaccination policy for Turkey.
    Egemen A; Aksit S; Ozacar T; Kurugol Z; Keskinoglu P; Pehlivan T; Mutlu S
    Pediatr Int; 2001 Aug; 43(4):379-84. PubMed ID: 11472583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between seroprevalence of measles and various social determinants in the year following a measles outbreak in Turkey.
    Emek M; Islek D; Atasoylu G; Ozbek OA; Ceylan A; Acikgoz A; Tay Z; Demiral Y; Oktem MA; Unal B
    Public Health; 2017 Jun; 147():51-58. PubMed ID: 28404496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C; Mankertz A
    Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey.
    Aksit S; Egemen A; Ozacar T; Kurugol Z; Keskinoglu P; Tasbakan M; Caglayan S
    Pediatr Infect Dis J; 1999 Jul; 18(7):577-80. PubMed ID: 10440431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles seroprevalence of an adolescent population vaccinated with a single dose of measles vaccine before their first birthday.
    Kanbur NO; Derman O; Kutluk T
    Int J Adolesc Med Health; 2005; 17(4):337-41. PubMed ID: 16445072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents].
    Poethko-Müller C; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1243-52. PubMed ID: 23990086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B and measles seroprevalence among Turkish children.
    Kanra G; Tezcan S; Badur S;
    Turk J Pediatr; 2005; 47(2):105-10. PubMed ID: 16052847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubella seroprevalence among healthy individuals in Izmir, Turkey.
    Kurugöl Z; Midyat L; Türkoğlu E; Ozacar T
    Hum Vaccin; 2011 Sep; 7(9):972-5. PubMed ID: 21860258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of susceptibility to measles in Italy. Serological Study Group.
    Salmaso S; Gabutti G; Rota MC; Giordano C; Penna C; Mandolini D; Crovari P
    Bull World Health Organ; 2000; 78(8):950-5. PubMed ID: 10994277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing epidemiology of measles in Turkey: need for reassessment of measles vaccination policy?
    Egemen A; Taşdemir I; Eker L; Arcasoy M
    J Trop Pediatr; 1996 Oct; 42(5):299-301. PubMed ID: 8936963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological survey of measles immunity in the Czech Republic, 2013.
    Tomášková H; Zelená H; Kloudová A; Tomášek I
    Cent Eur J Public Health; 2018 Mar; 26(1):22-27. PubMed ID: 29684293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles seroprevalence, outbreaks, and vaccine coverage in Rwanda.
    Seruyange E; Gahutu JB; Mambo Muvunyi C; Uwimana ZG; Gatera M; Twagirumugabe T; Katare S; Karenzi B; Bergström T
    Infect Dis (Lond); 2016; 48(11-12):800-7. PubMed ID: 27386895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination.
    Enquselassie F; Ayele W; Dejene A; Messele T; Abebe A; Cutts FT; Nokes DJ
    Epidemiol Infect; 2003 Jun; 130(3):507-19. PubMed ID: 12825737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of measles antibody and its attributable factors in elementary students of routine 2-dose schedule era with vaccination record].
    Bae GR; Lim HS; Goh UY; Yang BG; Kim YT; Lee JK
    J Prev Med Public Health; 2005 Nov; 38(4):431-6. PubMed ID: 16358829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the Population Susceptibility Against Measles in Slovakia.
    Zibolenová J; Chladná Z; Švihrová V; Baška T; Waczulíková I; Hudečková H
    Cent Eur J Public Health; 2017 Mar; 25(1):46-54. PubMed ID: 28399355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles seroepidemiology in 3 cities in Turkey.
    Gozalan A; Korukluoglu G; Kurtoglu D; Miyamura K; Yilmaz N; Morita M; Esen B; Akin L
    Saudi Med J; 2005 Dec; 26(12):1971-7. PubMed ID: 16380784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.